Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06380075 · ClinicalTrials.gov registry record · NA
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
A NA study of Retinal Disease, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06380075: Recruiting NA study of Retinal Disease, sponsored by University of Wisconsin, Madison.
NCT06380075 is a NA study of Retinal Disease that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 50 participants, below the 1,239-participant average among 19 other Retinal Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06380075, a NA study of Retinal Disease, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to compare two ultrawide field cameras to the gold standard imaging system to evaluate the back of the eye. The main question it aims to answer is the same results and information can be acquired from all of the cameras for evaluating and monitoring inherited retinal diseases (IRDs). Participants will: * undergo pupillary dilation * have photographs taken of the inside of the eyes using three different cameras
Primary Outcome
Graders will independently measure area of FAF retinal patterns from images of each device. The measurements (in mm²) will be compared between the two devices.
Conditions Studied
Interventions
- DEVICE Spectralis FAF imaging
- DEVICE Optos imaging
- DEVICE Clarus imaging
Study Locations (1)
Wisconsin
- Department of Ophthalmology and Visual Sciences - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-08-29 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06380075 shows while recruiting
NCT06380075 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,239-participant average among 19 other Retinal Disease trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Retinal Disease appearing as the primary indexed condition, and to 3 interventions - of which Spectralis FAF imaging is the first listed.
NCT06380075 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06380075 about?
NCT06380075 is a clinical study titled "COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease". The goal of this research study is to compare two ultrawide field cameras to the gold standard imaging system to evaluate the back of the eye. The main question it aims to answer is the same results and information can be acquired from all of the cameras for evaluating and monitoring inherited retin...
What is the current status of trial NCT06380075?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-08-29. Estimated completion is 2026-12.
What conditions does trial NCT06380075 study?
This clinical trial studies the following conditions: Retinal Disease.
What interventions are being tested in trial NCT06380075?
The interventions under investigation include: Spectralis FAF imaging (DEVICE), Optos imaging (DEVICE), Clarus imaging (DEVICE).
Who is sponsoring clinical trial NCT06380075?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06380075 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06380075's enrollment target sits among peer trials
50 11th of 19 higher than 9 of 19 other Retinal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Retinal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
P200TxE Diseased Eye Image Collection
RECRUITING · NA
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
RECRUITING
-
Data Gathering for A10900
RECRUITING
-
Inherited Retinal Degenerative Disease Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI